Mass Tort - Construction Site Accidents
- Unsafe Drugs
- Stock Market Losses
- Unsafe Products
- Environmental Toxins
- Personal Injury
- Employment Law
- Medical Malpractice
- Class Action
Practice Area Attorneys
Vioxx Resources
Sol Weiss speaking about Vioxx on Sky Radio (audio file)
Cox Inhibition by Naproxen & Low-Dose Aspirin
Gastrointestinal bleeding after the introduction of COX 2
inhibitors: Ecological Study
Relationship Between COX-2 Specific Inhibitors and Hypertension
Vioxx®
Contact us today for a free legal consultation about your Vioxx® case.
Click here to read the latest news on Vioxx Trials.
Vioxx® is a nonsteriodal anti-inflammatory drug (NSAID) formerly used to treat osteoarthritis, acute pain conditions and dysmenorrhoea.
Vioxx® is included in the group of NSAIDs known as COX-2 inhibitors or coxibs (CycloOxygenase-2 Inhibitors). In 2000, a study was completed by Merck known as the Vioxx® Gastrointestinal Outcomes Research or “VIGOR” clinical trial. In this trial, approximately 8,000 patients with arthritis participated taking either Vioxx®, Naproxen or other traditional pain killers. The VIGOR study indicated a significant four-fold increased risk of acute heart attack in Vioxx® patients when compared with Naproxen patients.
Nonetheless, the drug was approved and the FDA acted as a propaganda machine, catering to the interests of the drug companies. Meanwhile, people were dying.
On September 30, 2004, Merck voluntarily withdrew Vioxx® from the world market due to individuals suffering heart attacks and strokes. Over two million people were prescribed Vioxx® at that time. Merck was fully aware of the health risks of its Cox-2 inhibitor anti-inflammatory drug as early as March 2000. There was a concerted effort to bury negative evidence and even distort the drug trials by excluding heart patients from the Vioxx studies so that the rate of cardiovascular problems for Vioxx® patients would not be obvious.
On August 19, 2005, a jury awarded Carol Ernst $253.4 million dollars in damages as a result of the death of her husband from a heart attack after he took Vioxx® . The jury found Merck liable for lost pay, mental anguish, loss of companionship and punitive damages.
Anapol Schwartz has reviewed more than 1000 claims and filed lawsuits in New Jersey State Court on behalf of 86 individuals. We have experienced Vioxx injury attorneys and paralegals actively pursuing recoveries for our clients.
If you have taken Vioxx® and have been adversely affected, we can assist you in evaluating your case. Click here to contact us for a free case evaluation.
